Clinical Ophthalmology
Volume 15, 2021 - Issue
Open access
114
Views
2
CrossRef citations to date
0
Altmetric
Original Research
Aflibercept versus Ranibizumab as a Second Line Therapy After Bevacizumab for Diabetic Macular Edema
Nasser G Alsaedi1 King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia;2 King Abdullah Medical City, Makkah, Saudi Arabia
https://orcid.org/0000-0001-6299-6040
Ruba M Alselaimy3 College of Medicine, King Saud University, Riyadh, Saudi Arabia
, Abdulaziz A Alshamrani1 King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia
https://orcid.org/0000-0002-0392-0123
Muhammed AlAjmi4 Albahar Eye Centre, Kuwait City, Kuwait
, Rajiv Khandekar1 King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia
https://orcid.org/0000-0002-3925-1005
Hassan Al-Dhibi1 King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia
& Abdulelah A Al-Abdullah1 King Khaled Eye Specialist Hospital, Riyadh, Saudi ArabiaCorrespondence[email protected]
show all
Pages 2975-2980
|
Published online: 13 Jul 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.